Virgilio Evangelista
Mozzagrogna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis.
Journal: Frontiers in pharmacology
Published: April 29, 2021
Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High-Risk Patients for Cardiovascular Disease.
Journal: Clinical pharmacology and therapeutics
Published: January 12, 2018
Mechanisms of endothelial cell dysfunction in cystic fibrosis.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 04, 2017
The natural phosphoinositide derivative glycerophosphoinositol inhibits the lipopolysaccharide-induced inflammatory and thrombotic responses.
Journal: The Journal of biological chemistry
Published: December 29, 2016
Phosphodiesterase type 4 blockade prevents platelet-mediated neutrophil recruitment at the site of vascular injury.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: June 14, 2014
Effect of pioglitazone versus metformin on cardiovascular risk markers in type 2 diabetes.
Journal: Advances in therapy
Published: October 31, 2012
An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes.
Journal: PloS one
Published: January 31, 2012
Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse.
Journal: Thrombosis and haemostasis
Published: December 23, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026